Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)

NCT01624974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK-1029
DRUG: Placebo
DRUG: Montelukast (ML)

Sponsor

Merck Sharp & Dohme LLC